Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease-Reference-Cited by-同舟云学术

Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease

Published:2012-06-18 Issue:4 Volume:30 Page:943-961
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Searcy James L.¹,Phelps Jeremiah T.¹,Pancani Tristano¹,Kadish Inga²,Popovic Jelena¹,Anderson Katie L.¹,Beckett Tina L.³,Murphy Michael P.³,Chen Kuey-Chu¹,Blalock Eric M.¹,Landfield Philip W.¹,Porter Nada M.¹,Thibault Olivier¹

Affiliation:

1. Department of Molecular and Biomedical Pharmacology, University of Kentucky Medical Center, Lexington, KY, USA

2. Department of Cell Biology, University of Alabama, Birmingham, AL, USA

3. Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges;Life Sciences;2024-10

2. PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease;Medicinal Chemistry;2024-10

3. Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease;Neurobiology of Disease;2024-10

4. PPARγ activation ameliorates cognitive impairment and chronic microglial activation in the aftermath of r-mTBI;Journal of Neuroinflammation;2024-08-03

5. HIF-1α serves as a co-linker between AD and T2DM;Biomedicine & Pharmacotherapy;2024-02